EU scheme commits $350 million for research on Ebola vaccines, tests
By Ben Hirschler LONDON (Reuters) – The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) in Ebola research, with the lion's share going to the testing and manufacture of potential vaccines. The funding will go to projects backed by the Innovative Medicines Initiative (IMI), a public-private scheme jointly paid for by the European Commission and the pharmaceuticals industry. Reuters reported on Oct. 22 that an IMI investment of around 200 million euros was pending. …
